Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Haase

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Neuroreport|March 25, 1998
Cerebral hemodynamics during electrically induced seizuresJ Vollmer-Haase, H W Folkerts, C G Haase, et al.
European Neurology|July 27, 2004
Cognitive, but not mood dysfunction develops in multiple sclerosis during 7 years of follow-upC G Haase, M Tinnefeld, I Daum, et al.
Journal of Neuroimmunology|August 30, 2001
Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosisS Schmidt, C G Haase, L Bezman, et al.
British Journal of Cancer|May 5, 2005
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumoursA Awada, A Hendlisz, T Gil, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 16, 2004
Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancerH Richly, P Kupsch, K Passage, et al.
Journal of Neuroimmunology|March 10, 2001
The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controlsC G Haase, J Guggenmos, U Brehm, et al.
Ecology|November 19, 2016
Energetic costs of mange in wolves estimated from infrared thermographyP C Cross, E S Almberg, C G Haase, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumorsK Mross, H Richly, N Schleucher, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Neuroreport|March 25, 1998
Cerebral hemodynamics during electrically induced seizuresJ Vollmer-Haase, H W Folkerts, C G Haase, et al.
European Neurology|July 27, 2004
Cognitive, but not mood dysfunction develops in multiple sclerosis during 7 years of follow-upC G Haase, M Tinnefeld, I Daum, et al.
Journal of Neuroimmunology|August 30, 2001
Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosisS Schmidt, C G Haase, L Bezman, et al.
British Journal of Cancer|May 5, 2005
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumoursA Awada, A Hendlisz, T Gil, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 16, 2004
Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancerH Richly, P Kupsch, K Passage, et al.
Journal of Neuroimmunology|March 10, 2001
The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controlsC G Haase, J Guggenmos, U Brehm, et al.
Ecology|November 19, 2016
Energetic costs of mange in wolves estimated from infrared thermographyP C Cross, E S Almberg, C G Haase, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumorsK Mross, H Richly, N Schleucher, et al.
Pageof 2